Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis Read more
Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to Treat COVID-19 Read more
Pandion Announces First Subject Dosed in a Phase 1 Clinical Trial of PT101, an IL-2 Mutein Fc Fusion Therapy for Autoimmune Disease Read more
STADA becomes a major Consumer Healthcare player by acquiring 15 well-established GSK brands Read more